Oxford Biodynamics partners with Goodbody Clinic on PSE test
Oxford BioDynamics, which is developing precision medicine tests based on the EpiSwitch 3D genomics platfor, has signed an agreement with the Goodbody Clinic, the Bath-headquartered nationwide provider of private health testing services, to give its patients access to OBD's EpiSwitch PSE (EpiSwitch Prostate Screening) blood test.
OBD's EpiSwitch PSE test is a blood test that boosts the predictive accuracy of a standard PSA test from 55 per cent to 94 per cent when testing for the presence or absence of prostate cancer, which was launched in the UK and US in September last year.
The Goodbody Clinic offers customers private health testing using a network of more than 140 clinics nationwide.
Using the Goodbody Clinic website, men can request to order a PSE test from one of the clinics' registered GPs, pay for their test, and book an appointment for their blood sample to be taken at their local clinic. The Goodbody Clinic will also provide a remote doctor's referral and consultation to support patients to ensure they receive the appropriate care.
For those unable to visit one of the Goodbody clinics, men will have the option of having their PSE blood sample drawn at any location by booking a mobile nurse visit. The Goodbody Clinic operates a growing network of mobile phlebotomists across the UK, operating from Scotland down to Cornwall.
George Thomas, Chief Executive Officer of Goodbody Clinic, said: "The rapid EpiSwitch PSE test can significantly enhance the accuracy of detecting prostate cancer, allowing us to provide better care and peace of mind to men throughout the whole country. We are always looking to advance our commitment to accessible, high-quality healthcare by combining the latest innovations like the PSE with access to Goodbody's convenient clinics and home testing solutions."
